Extracorporeal management of valproic acid toxicity: A case report and review of the literature

Seminars in Dialysis

Volumn 18, Issue 1, 2005, Pages 62-66

  Al Aly, Ziyad ^a   Yalamanchili, Praveen ^b   Gonzalez, Esther ^a  

^a SAINT LOUIS UNIVERSITY   (United States)

^b ST LUKE S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VALPROIC ACID;

ADULT; BIPOLAR DISORDER; BLOOD ANALYSIS; BLOOD FLOW; CASE REPORT; CONSULTATION; DIALYSATE; DIALYSIS MEMBRANE; DISEASE COURSE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMODYNAMICS; HEMOFILTRATION; HEMOPERFUSION; HUMAN; HYDRATION; INTUBATION; LABORATORY TEST; LETHARGY; MALE; MEDICAL LITERATURE; PLASMA CLEARANCE; RESPIRATORY FAILURE; RESUSCITATION; REVIEW; TOXICITY; TREATMENT OUTCOME; ULTRAFILTRATION; UNCONSCIOUSNESS; VEIN;

EID: 14844310922     PISSN: 08940959     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2005.18106.x     Document Type: Review

References (27)

1. Johannessen CU, Johannessen SI: Valproate: past, present, and future. CNS Drug Rev 9:199-216, 2003
2. Doyon S: Anticonvulsants. In: Goldfrank L, Flomenbaum N, Lewin N, Howland MA, Hoffman R, Nelson L (eds). Goldfrank's Toxicologic Emergencies. New York: McGraw-Hill, 2002
3. McNamara J: Drugs effective in the therapy of epilepsies. In: Hardman JG, Limbird LE, Molinoff PB, Ruddon RW, Gilman AG (eds). Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: McGrawHill, 1996:476
4. Chadwick DW: Concentration-effect relationships of valproic acid. Clin Pharmacokinet 10:155-163, 1985
5. Gugler R, von Unruh GE: Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet 5:67-83, 1980
6. Watson WA, Litovitz TL, Rodgers GC Jr, Klein-Schwartz W, Youniss J, Rose SR, Borys D, May ME: 2002 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med 21:353-421, 2003
7. Alberto G, Erickson T, Popiel R, Narayanan M, Hryhorczuk D: Central nervous system manifestations of a valproic acid overdose responsive to naloxone. Ann Emerg Med 18:889-891, 1989
8. Steiman GS, Woerpel RW, Sherard ES Jr: Treatment of accidental sodium valproate overdose with an opiate antagonist. Ann Neurol 6:274, 1979
9. Montera FJ: Naloxone in the reversal of coma induced by sodium valproate. Ann Emerg Med 33:357-358, 1999
10. Ohtani Y, Matsuda I: Valproate treatment and carnitine deficiency. Neurology 34:1128-1129, 1984
11. Ohtani Y, Endo F, Matsuda I: Carnitine deficiency and hyperammonemia associated with valproic acid therapy. J Pediatr 101:782-785, 1982
12. Gidal BE, Inglese CM, Meyer JF, Pitterle ME, Antonopolous J, Rust RS: Diet- and valproate-induced transient hyperammonemia: effect of L-carnitine. Pediatr Neurol 16:301-305, 1997
13. Bruni J, Wang LH, Marbury TC, Lee CS, Wilder BJ: Protein binding of valproic acid in uremic patients. Neurology 30:557-559, 1980
14. Kandrotas RJ, Love JM, Gal P, Oles KS: The effect of hemodialysis and hemoperfusion on serum valproic acid concentration. Neurology 40:1456-1458, 1990
15. Zaccara G, Messori A, Moroni F: Clinical pharmacokinetics of valproic acid - 1988. Clin Pharmacokinet 15:367-389, 1988
16. Klotz U, Antonin KH: Pharmacokinetics and bioavailability of sodium valproate. Clin Pharmacol Ther 21:736-743, 1977
17. Kane SL, Constantiner M, Staubus AE, Meinecke CD, Sedor JR: High-flux hemodialysis without hemoperfusion is effective in acute valproic acid overdose. Ann Pharmacother 34:1146-1151, 2000
18. Franssen EJ, van Essen GG, Portman AT, de Jong J, Go G, Stegeman CA, Uges DR: Valproic acid toxicokinetics: serial hemodialysis and hemoperfusion. Ther Drug Monit 21:289-292, 1999
19. Brubacher JR, Dahghani P, McKnight D: Delayed toxicity following ingestion of enteric-coated divalproex sodium (Epival). J Emerg Med 17:463-467, 1999
20. Johnson LZ, Martinez I, Fernandez MC, Davis CP, Kasinath BS: Successful treatment of valproic acid overdose with hemodialysis. Am J Kidney Dis 33:786-789, 1999
21. Hicks LK, McFarlane PA: Valproic acid overdose and haemodialysis. Nephrol Dial Transplant 16:1483-1486, 2001
22. Dharnidharka VR, Fennell RS 3rd, Richard GA: Extracorporeal removal of toxic valproic acid levels in children. Pediatr Nephrol 17:312-315, 2002
23. Matsumoto J, Ogawa H, Maeyama R, Okudaira K, Shinka T, Kuhara T, Matsumoto I: Successful treatment by direct hemoperfusion of coma possibly resulting from mitochondrial dysfunction in acute valproate intoxication. Epilepsia 38:950-953, 1997
24. Graudins A, Aaron CK: Delayed peak serum valproic acid in massive divalproex overdose - treatment with charcoal hemoperfusion. J Toxicol Clin Toxicol 34:335-341, 1996
25. Tank JE, Palmer BF: Simultaneous "in series" hemodialysis and hemoperfusion in the management of valproic acid overdose. Am J Kidney Dis 22:341-344, 1993
26. Kay TD, Playford HR, Johnson DW: Hemodialysis versus continuous venovenous hemodiafiltration in the management of severe valproate overdose. Clin Nephrol 59:56-58, 2003
27. Roodhooft AM, Van Dam K, Haentjens D, Verpooten GA, Van Acker KJ: Acute sodium valproate intoxication: occurrence of renal failure and treatment with haemoperfusion-haemodialysis. Eur J Pediatr 149:363-364, 1990